Immunohematology

Keyphrases

Publications

volume 40, number 1, 2024

Genghis H Lopez, Mia E Sarri, Robert L Flower, Catherine A Hyland
Impact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review. Immunohematology 40 (1) (2024)
Janis R Hamilton
An update to Kidd blood group system. Immunohematology 40 (1) (2024)
Janis R Hamilton
An update to Kidd blood group system. Immunohematology 40 (1) (2024)
Frederik B Clausen
Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women. Immunohematology 40 (1) (2024)
Stella T Chou, Sandra T Nance, Paul Mansfield, David F Friedman, Margaret A Keller
Meeting the transfusion needs of a patient with anti-En a requires an international effort. Immunohematology 40 (1) (2024)
Frederik B Clausen
Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women. Immunohematology 40 (1) (2024)
Genghis H Lopez, Mia E Sarri, Robert L Flower, Catherine A Hyland
Impact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review. Immunohematology 40 (1) (2024)
Stella T Chou, Sandra T Nance, Paul Mansfield, David F Friedman, Margaret A Keller
Meeting the transfusion needs of a patient with anti-En a requires an international effort. Immunohematology 40 (1) (2024)

volume 40, number 2, 2024

Thompson J Akinbolaji
When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature. Immunohematology 40 (2) (2024)
Thompson J Akinbolaji
When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature. Immunohematology 40 (2) (2024)
Sunil Golia, Samruddhi Pawar, Aseem K Tiwari, Geet Aggarwal, Neetu Singh, Shubham Gupta
A patient with anti-f in India identified by extensive immunohematologic workup. Immunohematology 40 (2) (2024)
Sudipta S Das, Soumya Das, Soma Agrawal, Shamee Shastry, Veena Shenoy, Suvro S Datta
A national survey of current immunohematologic testing practices for the diagnosis of autoimmune hemolytic anemia in India. Immunohematology 40 (2) (2024)
Gavin Patch, Joan Maurer, Arun Sendilnathan, Christine Leak, Elizabeth Nartowicz, Victoria Kavitsky, Dexter Facey, Sandra T Nance, Margaret A Keller
How anti-c in a D- patient prompted lifesaving work between a transfusion service and a blood center reference laboratory. Immunohematology 40 (2) (2024)
Carine P Arnoni, Tatiane A Vendrame, Flavia S Silva, Nayara M Silva, Afonso Cortez, Flavia Latini, Lilian Castilho
Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization. Immunohematology 40 (2) (2024)

volume 39, number 1, 2023

S Sawadogo, K Nebie, S K A Ouedraogo, C Traore, J Koulidiati, M Nikiema-Minoungou, N G Koala, E Kafando, V Deneys
Extended red blood cell antigens and phenotypes in Burkina Faso: potential issues to design local population-sourced red blood cell reagent panels. Immunohematology 39 (1) (2023)
D Sahoo, S Anuragaa, B Abhishekh
Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report. Immunohematology 39 (1) (2023)
J W Jacobs, E Abels, T C Binns, C A Tormey, N Sostin
Hemolytic disease of the fetus and newborn mediated by anti-Di a in a U.S. hospital. Immunohematology 39 (1) (2023)
D S Parchure, G V Mishra, S S Kulkarni
Overview of the serologic and molecular basis of D variants with a focus on D variants in the Indian population. Immunohematology 39 (1) (2023)
X Yang, J M Syrjamaki, P A Ruegsegger, C T Rohrer, W N Rose
Practical evaluation of a warm-reactive anti-M. Immunohematology 39 (1) (2023)
L Stenfelt, Å Hellberg, M L Olsson
SID: a new carbohydrate blood group system based on a well-characterized but still mysterious antigen of great pathophysiologic interest. Immunohematology 39 (1) (2023)

volume 39, number 2, 2023

E C McGowan, J R Storry
The LW blood group system: not just "tagging along" with D. Immunohematology 39 (2) (2023)
K Bowman, L A Peña Marquez, L Hawthorne, K Billingsley, S Kelham, S Liang, M Kalvelage
A comparison of results from antihuman globulin-graded reactions with the monocyte monolayer assay. Immunohematology 39 (2) (2023)
J Novoselac, K Buzina Marić, V Rimac, I Selak, M Raos, B Golubić Ćepulić
Significance of immunohematologic testing in mother and newborn ABO incompatibility. Immunohematology 39 (2) (2023)
S J T Nance
The monocyte monolayer assay, an in vitro method for prediction of in vivo survival of transfused incompatible red blood cells: a review. Immunohematology 39 (2) (2023)
C E George, S Grimsley, R Cumber, N Thornton, H Davies, C Harris, E Massey, K Perera
Transfusion of incompatible blood to a patient with alloanti-Sc1. Immunohematology 39 (2) (2023)

volume 39, number 3, 2023

Gwen Clarke, Jelena Holovati
The Specialist in Transfusion Science program. Immunohematology 39 (3) (2023)
Susan T Johnson
Proud to be a medical laboratory scientist. Immunohematology 39 (3) (2023)
T C S Silva, M R Dezan, B R Cruz, S S M Costa, C L Dinardo, J O Bordin
Standardization of a multiplex assay to identify weak D types in a mixed-race Brazilian population. Immunohematology 39 (3) (2023)
G M Meny, M A Keller, C Flickinger
Update on programs for achieving Specialist in Blood Banking certification in the United States: 2023. Immunohematology 39 (3) (2023)
Peter D Issitt
Peter D. Issitt (1933-2023). Immunohematology 39 (3) (2023)

volume 39, number 4, 2023

Patricia Tippett
Peter D. Issitt (1933-2023). Immunohematology 39 (4) (2023)
D R Sanders
Comparison of solid-phase red cell adherence and microcolumn agglutination technology using untreated and enzyme-treated red blood cells. Immunohematology 39 (4) (2023)
J T Little, D P Blackall
Evaluation of solid-phase panreactivity with negative direct antiglobulin testing. Immunohematology 39 (4) (2023)
S Sawadogo, K Nebie, D Kima, S K A Ouedraogo, P A Nagnon, J Koulidiati, C Traore, S Sawadogo, E Kafando, V Deneys
Feasibility and performance of in-house red blood cell reagents to detect unexpected antibodies in immunized patients in Burkina Faso. Immunohematology 39 (4) (2023)
Patricia Tippett
Peter D. Issitt (1933-2023). Immunohematology 39 (4) (2023)
S Sawadogo, K Nebie, D Kima, S K A Ouedraogo, P A Nagnon, J Koulidiati, C Traore, S Sawadogo, E Kafando, V Deneys
Feasibility and performance of in-house red blood cell reagents to detect unexpected antibodies in immunized patients in Burkina Faso. Immunohematology 39 (4) (2023)
J T Little, D P Blackall
Evaluation of solid-phase panreactivity with negative direct antiglobulin testing. Immunohematology 39 (4) (2023)
M Mikame, N H Tsuno, Y Miura, H Kitazaki, D Uchimura, T Miyagi, T Miyazaki, T Onodera, W Ohashi, T Kameda, R Ohkawa, S Kino, K Muroi
Anti-A and anti-B titers, age, gender, biochemical parameters, and body mass index in Japanese blood donors. Immunohematology 39 (4) (2023)
D R Sanders
Comparison of solid-phase red cell adherence and microcolumn agglutination technology using untreated and enzyme-treated red blood cells. Immunohematology 39 (4) (2023)
M Mikame, N H Tsuno, Y Miura, H Kitazaki, D Uchimura, T Miyagi, T Miyazaki, T Onodera, W Ohashi, T Kameda, R Ohkawa, S Kino, K Muroi
Anti-A and anti-B titers, age, gender, biochemical parameters, and body mass index in Japanese blood donors. Immunohematology 39 (4) (2023)

volume 33, number 4, 2023

T Horn, J Hamilton, J Kosanke, V W Hare, W Kluver, W Beres, S Nance, M A Keller
Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype. Immunohematology 33 (4) (2023)

volume 38, number 4, 2022

Margaret A Keller, Cynthia Flickinger
To contributors to the 2022 issues. Immunohematology 38 (4) (2022)
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Post COVID-19 vaccination and adverse events: correspondence. Immunohematology 38 (4) (2022)
M D Ilsley, J R Storry, M L Olsson
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system. Immunohematology 38 (4) (2022)
C P Arnoni, T A P Vendrame, F S Silva, A J P Cortez, F R M Latini, L Castilho
RHCE variant alleles and risk of alloimmunization in Brazilians. Immunohematology 38 (4) (2022)
Sheetal Malhotra, Ashish Jain, Ratti Ram Sharma, Srinivasan Peyam
Rare case of clinically significant anti-c in a 1-year-old pediatric patient. Immunohematology 38 (4) (2022)
M D Ilsley, J R Storry, M L Olsson
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system. Immunohematology 38 (4) (2022)
H Ohto, M Uchikawa, S Ito, I Wada, K E Nollet, Y Omae, K Ogasawara, K Tokunaga
The KANNO blood group system. Immunohematology 38 (4) (2022)
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Post COVID-19 vaccination and adverse events: correspondence. Immunohematology 38 (4) (2022)
Sandra Nance
Use of e VAR and anti-e VAR as interim terms. Immunohematology 38 (4) (2022)